ARTICLE | Clinical News
Thetanix: Phase I started
September 5, 2016 7:00 AM UTC
4D Pharma began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral Thetanix in about 20 patients ages 16-18. In the first part, 10 patients will receive a single dose of Thetanix....